Through the collective examination of 1,757 individuals with EoE and 93,338 individuals with atopic disease, GWAS identified 11 variants across 8 risk loci; 3 of these loci were novel and included regions near classical immune regulators, such as GATA3 and IL4R. This evidence concerns the gene GATA3 and eosinophilic esophagitis.